The Drugs Controller General of India (DCGI) on June 29, 2021 granted permission to Cipla to import Moderna’s Covid-19 vaccine for restricted emergency use in the country.
- With Moderna’s approval, India now has four vaccines which have been granted emergency use authorisation, the other three being Covishield, Covaxin and Sputnik V.
- Modern’a mRNA-1273 vaccine against Coronavirus are genetic material that our cells read to make proteins.
- The vaccine is sold under the brand name ‘Spikevax’ in the United States. It was developed by the pharmaceutical company in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA) in the US.
